Are NSAIDs Useful to Treat Alzheimer’s Disease or Mild Cognitive Impairment?

Frontiers in Aging Neuroscience - Switzerland
doi 10.3389/fnagi.2010.00019
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Frontiers Media SA

Related search

Decision-Making Under Ambiguity or Risk in Individuals With Alzheimer’s Disease and Mild Cognitive Impairment

Frontiers in Psychiatry
PsychiatryMental Health
2020English

The Effects of Bioactive Compounds on Alzheimer’s Disease and Mild Cognitive Impairment

Functional Foods in Health and Disease
2016English

Depressive Symptom Endorsement Among Alzheimer’s Disease, Vascular Dementia and Mild Cognitive Impairment

Open Journal of Medical Psychology
2012English

Increased EEG Gamma Band Activity in Alzheimer’s Disease and Mild Cognitive Impairment

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2008English

Autophagy and Mitophagy Biomarkers Are Reduced in Sera of Patients With Alzheimer’s Disease and Mild Cognitive Impairment

Scientific Reports
Multidisciplinary
2019English

Metabolic Profiles Help Discriminate Mild Cognitive Impairment From Dementia Stage in Alzheimer’s Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2020English

Sex Differences in Cognitive Decline in Subjects With High Likelihood of Mild Cognitive Impairment Due to Alzheimer’s Disease

Scientific Reports
Multidisciplinary
2018English

Alzheimer’s Disease Polygenic Risk Score as a Predictor of Conversion From Mild-Cognitive Impairment

Translational Psychiatry
PsychiatryMolecular NeuroscienceBiological PsychiatryMental HealthCellular
2019English

Early Detection of Mild Cognitive Impairment and Mild Alzheimer’s Disease in Elderly Using CBF Activation During Verbally-Based Cognitive Tests

2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy